CancerConfidential

(pavlina) #1
Page 49

#11. Supernutrient Vitamin C

The cancer-curative properties of vitamin C is its most controversial benefit by
far. Oncologists hate it and regular media splurges try to discredit it and even
claim it causes cancer, based on a very miserable inadequate study showing if
you drenched chromosomes in vitamin C in a test tube there were minor changes
which MIGHT (they said) indicate a cancer risk.


Having used it IV for over 2 decades with cancer patients I can attest with
certainty to its beneficial effects.


One good study showed a cytotoxic effect (like chemo) against cancer cells at
around 3 grams per 100 mls in blood. That’s way below any possible toxic effect
in humans, although these levels could only be achieved by the IV administration
route.


In fact there is no such thing as a toxic effect from vitamin C. None ever
recorded, even at doses over 300- 400 grams IV. It really is remarkable.


[Please note a study in 2008 which showed that vitamin C in the presence of
fats in the stomach created more nitrosamines. We know nitrosamines are
carcinogenic. It’s a paradox because vitamin C, without fats, normally LOWERS
nitrosamine levels in the stomach. The culprit is really the fats.


Most objective studies show vitamin C significantly decreases cancer of the
mouth, esophagus, stomach, colon, rectum and lung. One prospective study of
870 men over a period of 25 years found that those who consumed more than
83 mg of vitamin C daily had a striking 64% reduction in lung cancer compared
with those who consumed less than 63 mg per day. That’s a 2/3rds reduction:
pretty hard to argue with.


Although most large prospective studies found no association between breast
cancer and vitamin C intake, two recent studies found dietary vitamin C intake to
be inversely associated with breast cancer risk in certain subgroups.


In the Nurses’ Health Study, premenopausal women with a family history of
breast cancer who consumed an average of 205 mg/day of vitamin C from foods
had a 63% lower risk of breast cancer than those who consumed an average of
70 mg/day.


In the Swedish Mammography Cohort, women who were overweight and
consumed an average of 110 mg/day of vitamin C had a 39% lower risk of
breast cancer compared to overweight women who consumed an average of 31
mg/day.

Free download pdf